GENEVA, June 19 -- IMMATICS BIOTECHNOLOGIES GMBH filed a patent application (EP2025/082828) for “DOSING OF PRAME-SPECIFIC TCER”. With publication no. WO/2026/104504, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....